VSWarehouse for Genome Centers: Scalable, Secure Whole-Genome Infrastructure for Modern Sequencing Programs

VSWarehouse Logo

About this webinar

December 10, 2025 // 12:00 PM EST

Presented By: Gabe Rudy, VP Product and Engineering

Genome centers operating at scale require a platform that can process whole genomes efficiently while maintaining strict security, allowing flexible collaboration, and ensuring reliable, validated operations. VSWarehouse delivers an enterprise-grade foundation for large-volume germline and somatic workflows, enabling organizations to manage data, users, and infrastructure with complete sovereignty: on-premises, air-gapped, or across federated sites.

In this webcast, we will highlight how VSWarehouse empowers genome centers to operate with confidence:
  • Whole-genome–optimized pipelines supporting germline singletons/duos/trios and somatic tumor–normal workflows at scale.
  • Workspace architecture that partitions teams and projects while allowing controlled collaboration within each workspace.
  • Cohort-level allele frequency generation from thousands of genomes to power population-aware interpretation.
  • Enterprise security with SAML/LDAP SSO, full air-gapped deployment support, and a validated, penetration-tested architecture.
  • Join us to see how VSWarehouse provides the secure, scalable, and enterprise-ready platform genome centers need to power population-scale sequencing programs and high-assurance clinical analysis.


    Watch on demand

    Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.

    Download the slide deck

    To download a copy of the slides, visit our SlideShare page. From there, you can browse through our presentations and either clip your favorite slides or download the entire deck directly to your computer.

    Love this webcast? Check out more!

    Find out how Golden Helix software enables users to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.